BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare...
Former FDA Associate Commissioner Peter Pitts and BrainStorm's Chaim Lebovits argue that regulation must keep pace with advances in biomarkers, AI, cell therapy and precision medicine NEW YORK,...
ir.brainstorm-cell.com